Participants 336 424 6
G-CSF group which received chemotherapy with G-CSF and historical controls without G-CSF
Participants 439 596 9
132 patients with hematological malignancy in complete remission without any main organ dysfunction who had been treated between April 1983 and December 1997
Participants 667 693 4
those who received G-CSF a
Participants 696 713 4
those who did not
